ALSPW.PA Spineway SA EURONEXT down 9.98% on 09 Jan 2026: watch €0.15 support
ALSPW.PA stock plunged 9.98% to €0.1642 at market close on 09 Jan 2026, led by heavy intraday selling and above-average volume. The microcap medical device maker Spineway SA (ALSPW.PA) saw 572,722 shares trade versus a 50-day average of 624,611, signalling elevated liquidity and short-term pressure. Today’s range was €0.151–€0.171 with a previous close of €0.1824. We summarise price drivers, technical support, valuation metrics and a model forecast to help investors assess near-term risk and reward.
ALSPW.PA stock: intraday move and volume
The main fact is the one-day fall of 9.98% to €0.1642 on EURONEXT (Europe). Trading volume reached 572,722 shares, above average and giving the move conviction. The day low was €0.151 and day high €0.171. Relative volume sits at 2.18, showing outsized participation for a stock with market cap €157,763 and 832,962 shares outstanding.
Technical picture for ALSPW.PA stock
Momentum indicators show near-term strength but overbought pockets: RSI 67.40 and CCI 256.75. ADX at 28.03 signals a strong trend. Price sits above the 50-day average €0.157 and above the 200-day average €0.13691, but broke the prior session close. Immediate support: €0.15 (today’s low and lower Bollinger band). Immediate resistance: €0.17 then the year high €0.26. A failure below €0.15 would target 200-day area €0.1369.
Valuation, fundamentals and sector context
Spineway reports EPS €0.01 and a quoted PE of 18.94 in the full quote. Key balance ratios: current ratio 2.34, cash per share €0.1186, and book value per share €0.7027. Gross margin is 54.42% but net margin is negative -16.99%, highlighting profitability pressure. As a Medical – Instruments & Supplies company, ALSPW.PA trades in the Healthcare cohort, where the sector YTD is +4.37%. The healthcare backdrop is modestly positive, but Spineway’s microcap scale and thin market capitalisation increase liquidity and execution risk.
Meyka Grade and model view for ALSPW.PA stock
Meyka AI rates ALSPW.PA with a score out of 100: 64.71 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score reflects stable cash metrics (current ratio 2.34) but mixed profitability. Note this grade is informational and not financial advice. Meyka AI’s forecast model projects €0.17 (monthly), implying +3.53% vs current price €0.1642. Forecasts are model-based projections and not guarantees.
Risks and catalysts affecting ALSPW.PA stock
Key near-term risks: thin market cap €157,763, inventory days 185.07, and negative net income per share €-0.0558 which can amplify volatility. Catalysts include contract wins, regulatory clearances, or better-than-expected earnings (next announcement: 24 Mar 2025 per the quote). Watch liquidity: average volume 624,611 and today’s 572,722 indicate tradeability but potential bid-ask swings for larger orders.
Peers, news flow and what traders should watch
Peer comparisons and recent coverage can shift sentiment quickly. A recent peer comparison on Investing.com shows relative moves for small European orthopedics players Investing.com comparison. Monitor updates on product sales, export growth and manufacturing cadence. For quick reference and live tickers see Spineway’s profile on Meyka: Spineway ALSPW.PA on Meyka.
Final Thoughts
Key takeaways: ALSPW.PA stock closed down 9.98% at €0.1642 on 09 Jan 2026, with elevated volume and a breakout below the prior close. Technicals show support at €0.15 and resistance at €0.17, while the 50-day average €0.157 and 200-day average €0.13691 provide trend context. Valuation is mixed: a reported PE 18.94 and EPS €0.01 sit alongside negative net income metrics and strong gross margins. Meyka AI’s forecast model projects €0.17 (monthly), a +3.53% upside from current price. For scenario planning, we use a conservative downside target €0.12 (approx -26.9%) and an upside reference at the year high €0.26 (+58.37%). Given the microcap size, investors should weigh execution and liquidity risk versus product-led growth catalysts. This analysis uses data from market quotes and the Meyka AI-powered market analysis platform; forecasts and grades are model-based and not guarantees.
FAQs
What drove the ALSPW.PA stock drop today?
The drop was driven by above-average volume of 572,722 shares, a fall from €0.1824 to €0.1642, and short-term profit-taking. Microcap liquidity and negative trailing margins increased selling pressure.
What is the short-term outlook for ALSPW.PA stock?
Short term, expect support at €0.15 and resistance at €0.17. Meyka AI’s model projects €0.17 (monthly), implying +3.53% from current price, with volatility likely given small market cap.
Does Meyka AI give a rating for ALSPW.PA stock?
Yes. Meyka AI rates ALSPW.PA 64.71 out of 100 | Grade B | Suggestion: HOLD. The grade factors benchmark, sector, financials and analyst signals and is informational, not advice.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
